MapNeuro uses molecular methods to generate brain-wide maps of neuronal connectivity and gene expression at the cellular level. MapNeuro is now using these technologies to build a new in-vivo discovery platform for neurodegenerative and psychiatric diseases.

The startup represented here is a graduate of Endless Frontier Labs’ predecessor program, called Creative Destruction Lab-New York City, operated by NYU in partnership with University of Toronto during 2018-2019. The Endless Frontier Labs has no current engagement or affiliation with the Creative Destruction Lab.